Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
12-Jun-2024
INOVIQ completes $7m placement
11-Jun-2024
INOVIQ MST Access Investor Presentation
7-Jun-2024
Trading Halt
3-Jun-2024
Breakthrough Exosome Therapy
30-Apr-2024
Quarterly Activities Report and Appendix 4C - March 2024
19-Apr-2024
Ovarian Cancer Test Validation
17-Apr-2024
INOVIQ Investor Update
16-Apr-2024
INOVIQ Investor Webinar
15-Apr-2024
INOVIQ and Promega sign Global EXO-NET Agreement
12-Apr-2024
INOVIQ (ASX:IIQ) - Webinar Presentation
Previous
1
2
3
4
Next
